Best practices to operationalize AI and automation in PV
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
Explore how regulatory teams are leveraging GenAI and advanced automation to streamline operations, increase precision, and stay compliant.
Moderator Garrett Hess Senior Director, Product Marketing ...
Join our webinar to hear from industry professionals how automation is helping literature teams accelerate regulatory compliance, enhance scalability, and focus.
Discover how our modular solutions can help you revolutionize the capture of safety-relevant information.
Hosted by industry leaders, this in-depth session explores critical updates, trends, and best practices shaping the future of electronic submissions, IDMP adoption, and compliance strategies globally.
In this engaging panel discussion, global leaders in pharmaceutical IT and pharmacovigilance share their expertise on how to get the most value out of technology investments, achieving significant efficiency and cost savings.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved